Call for Abstract
Scientific Program
2nd International Conference on Epigenetics and Human Diseases, will be organized around the theme “Evolving Landscape of Epigenetics & Therapeutic Approaches for Human Diseases”
Human Diseases 2020 is comprised of 17 tracks and 76 sessions designed to offer comprehensive sessions that address current issues in Human Diseases 2020.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Putatively adaptive effects
- Track 1-2Inheritance of epigenetic marks
- Track 1-3Deleterious effects
- Track 2-1Mitocondrial DNA
- Track 2-2Coding DNA
- Track 2-3Crop epigenetics: hybridization and heterosis
- Track 2-4Natural variation and ecological epigenetics
- Track 2-5Heritability of epigenetic marks
- Track 3-1Cell types
- Track 3-2Viral vectors
- Track 3-3Human genetic engineering
- Track 4-1Epigenetic drugs
- Track 4-2Prospects for epigenetic therapy
- Track 4-3Clinical study of epigenetics and epitranscriptomics
- Track 4-4Psychopathy
- Track 4-5Social behavior of insects
- Track 5-1Methylation inhibiting drugs
- Track 5-2Bromodomain and inhibitors
- Track 5-3Histone cetylase (HAT) inhibitors
- Track 5-4Protein methyltransferase inhibitors
- Track 5-5Epigenetics meets endocrinology
- Track 5-6Future direction of epigenetic drugs
- Track 6-1Epigenetic mechanisms
- Track 6-2Genomes and epigenomes
- Track 6-3Computational epigenetics
- Track 6-4Cigarette smoking and epigenetics
- Track 7-1Behavioral epigenetics
- Track 7-2DNA methylation
- Track 7-3Cancer biomarkers
- Track 7-4Molecular biomarkers
- Track 8-1Immunological disease
- Track 8-2Drug addiction
- Track 8-3Mining the epitranscriptome
- Track 8-4NGSâ€based RNA modification techniques
- Track 8-5Physiological functions of RNA modifications
- Track 8-6RNA splicing
- Track 9-1Instruments used in epigenetics
- Track 9-2Epigenetics products
- Track 10-1Genomic variation in human
- Track 10-2Cancer genomics
- Track 10-3Cancer genome sequencing
- Track 10-4Cancer epigenetics
- Track 11-1Epigenetic effects of environmental exposures
- Track 11-2Toxicoepigenetics
- Track 11-3Epigenetics and environmental origins of cancer
- Track 11-4Diet and the epigenome
- Track 12-1DNA packaging
- Track 12-2Chromosome biology in agricultute
- Track 12-3Homo and hetero chromosome
- Track 12-4Autosomal chromosomes
- Track 12-5Chromosomal abnormalities
- Track 12-6Karyotyping
- Track 13-1Molecular cytogenetics
- Track 13-2Cytotaxonomy
- Track 13-3Cancer cytogenetics
- Track 13-4Fluorescent in situ hybridization
- Track 14-1Animal cloning epigenetics
- Track 14-2Animals models in epigenetic research
- Track 14-3Animal epigenetics examples
- Track 14-4Animal epigenetics welfare
- Track 15-1Epigenetic clock
- Track 15-2Epigenetic memory
- Track 15-3Epigenetic changes in aging
- Track 15-4DNA methylation changes during aging
- Track 15-5Histone modification changes during aging
- Track 16-1Epigenetics in human neurodevelopmental disorders
- Track 16-2Epigenetic regulation of gene expression
- Track 16-3Epigenetics in human disease prevention
- Track 16-4Epigenetics in reproductive health
- Track 16-5Epigenetics in cardiovascular disease
- Track 16-6Epigenetics in nervous system
- Track 16-7Epigenetics modification
- Track 17-1Autoimmune disease
- Track 17-2Stem cells
- Track 17-3Behaviour plasticity
- Track 17-4Microbial epigenetics